Literature DB >> 7036430

Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay.

S M Carroll, K T Karthigasu, D I Grove.   

Abstract

The sensitivity specificity of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis has been investigated. 45 men with long-standing strongyloidiasis were compared with the same number of age- and sex-matched control subjects. The ELISA detected antibody in 84% of patients with parasitologically proven strongyloidiasis. When the technique was compared with an indirect immunofluorescent assay (IFA), a high correlation coefficient was obtained. Specificity was demonstrated by observing a marked fall in optical density of pooled positive serum after prior incubation with Strongyloides ratti soluble antigen but not after incubation with antigens derived from Ascaris suum or Dirofilaria immitis. The test is simple and offers a useful method for the diagnosis of strongyloidiasis. In these patients it was more reliable than a single parasitological examination of faeces or duodenal contents.

Entities:  

Mesh:

Year:  1981        PMID: 7036430     DOI: 10.1016/0035-9203(81)90156-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Strongyloides stercoralis infection in a patient with sickle cell disease.

Authors:  D E Ferastraoaru; N N Jariwala; S P Jariwala
Journal:  Ann Trop Med Parasitol       Date:  2011-12

Review 2.  A history of hookworm vaccine development.

Authors:  Brent Schneider; Amar R Jariwala; Maria Victoria Periago; Maria Flávia Gazzinelli; Swaroop N Bose; Peter J Hotez; David J Diemert; Jeffrey M Bethony
Journal:  Hum Vaccin       Date:  2011-11-01

3.  Comparative assessment of the gelatin particle agglutination test and an enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis.

Authors:  J Sithithaworn; P Sithithaworn; T Janrungsopa; K Suvatanadecha; K Ando; M R Haswell-Elkins
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Surface labelling of Strongyloides ratti: stage-specificity and cross-reactivity with S. stercoralis.

Authors:  C Northern; D I Grove; A Warton; F T Lovegrove
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis.

Authors:  R M Genta; R W Douce; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

6.  Strongyloidiasis in Canadian Far East war veterans.

Authors:  E M Proctor; J L Isaac-Renton; W B Robertson; W A Black
Journal:  CMAJ       Date:  1985-11-01       Impact factor: 8.262

Review 7.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

8.  Specific IgE responses in human strongyloidiasis.

Authors:  J McRury; I T De Messias; P D Walzer; T Huitger; R M Genta
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

9.  Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE.

Authors:  Kate Mounsey; Therese Kearns; Melanie Rampton; Stacey Llewellyn; Mallory King; Deborah Holt; Bart J Currie; Ross Andrews; Thomas Nutman; James McCarthy
Journal:  Acta Trop       Date:  2014-07-19       Impact factor: 3.112

Review 10.  The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.

Authors:  Ana Requena-Méndez; Peter Chiodini; Zeno Bisoffi; Dora Buonfrate; Eduardo Gotuzzo; José Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.